Compare · ISRG vs MYO
ISRG vs MYO
Side-by-side comparison of Intuitive Surgical Inc. (ISRG) and Myomo Inc. (MYO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ISRG and MYO operate in Industrial Specialties (Health Care), so they compete in similar markets.
- ISRG is the larger of the two at $131.36B, about 2240.9x MYO ($58.6M).
- MYO has been more active in the news (10 items in the past 4 weeks vs 7 for ISRG).
- ISRG has more recent analyst coverage (25 ratings vs 3 for MYO).
- Company
- Intuitive Surgical Inc.
- Myomo Inc.
- Price
- -
- -
- Market cap
- $131.36B
- $58.6M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- AMEX
- IPO
- 2000
- 2017
- News (4w)
- 7
- 10
- Recent ratings
- 25
- 3
Intuitive Surgical Inc.
Intuitive Surgical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets da Vinci surgical systems, and related instruments and accessories in the United States and internationally. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D HD vision systems, skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures. It also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures; and provides SimNow, a cloud-enabled simulation platform, which allows surgeons to learn and practice their surgical skills; Iris, an augmented reality imaging product for use in kidney procedures; and Intuitive Cloud that enables proactive monitoring and software updates. In addition, the company offers EndoWrist Stapler, a wristed stapling instrument for resection, transection, and creation of anastomoses; EndoWrist One Vessel Sealers that are wristed single-use instruments for bipolar coagulation and mechanical transection of vessels up to 7mm in diameter and tissue bundles that fit in the jaws of the instrument; E-100 generator, an electrosurgical generator; SureForm 45 Curved-Tip stapler; and SynchroSeal for sealing and transection with a single pedal press. Additionally, the company sells various accessories comprising sterile drapes for ensuring sterile field during surgery; and vision products that include replacement 3D stereo endoscopes, camera heads, light guides, and other items that facilitate the use of the da Vinci Surgical System, as well as Ion endoluminal system for biopsies. Intuitive Surgical, Inc. was founded in 1995 and is headquartered in Sunnyvale, California.
Myomo Inc.
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to restore function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.
Latest ISRG
- EVP & Chief Mfg and Supply Cha Brosius Mark sold $59,439 worth of shares (154 units at $385.97) as part of a pre-agreed trading plan, decreasing direct ownership by 15% to 881 units (SEC Form 4)
- EVP & Chief Mfg and Supply Cha Brosius Mark sold $90,778 worth of shares (231 units at $392.98) as part of a pre-agreed trading plan, decreasing direct ownership by 18% to 1,035 units (SEC Form 4)
- Industrial Robot Installations Hit Record Highs as Global Labor Shortages Deepen
- Director Guthart Gary S sold $4,000,000 worth of shares (10,000 units at $400.00) as part of a pre-agreed trading plan (SEC Form 4)
- Intuitive Surgical upgraded by Oppenheimer with a new price target
- Director Ladd Amy L sold $179,903 worth of shares (472 units at $381.15) as part of a pre-agreed trading plan, decreasing direct ownership by 73% to 179 units (SEC Form 4)
- EVP & Chief Legal and Complian Loeb Gary sold $151,600 worth of shares (400 units at $379.00) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 5,320 units (SEC Form 4)
- EVP & Chief Mfg and Supply Cha Brosius Mark sold $19,539 worth of shares (56 units at $348.91) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 1,266 units (SEC Form 4)
- Intuitive Surgical downgraded by HSBC Securities with a new price target
- EVP & Chief Mfg and Supply Cha Brosius Mark sold $29,954 worth of shares (84 units at $356.60) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 1,322 units (SEC Form 4)
Latest MYO
- Amendment: Chief Medical Officer Kovelman Harry sold $30,329 worth of shares (17,500 units at $1.73), decreasing direct ownership by 14% to 105,733 units (SEC Form 4)
- Chief Medical Officer Kovelman Harry sold $29,896 worth of shares (17,250 units at $1.73), decreasing direct ownership by 14% to 105,983 units (SEC Form 4)
- Chief Medical Officer Kovelman Harry covered exercise/tax liability with 22,457 shares and was granted 55,149 shares, increasing direct ownership by 36% to 123,233 units (SEC Form 4)
- Chief Commercial Officer Mitchell Micah was granted 58,409 shares and covered exercise/tax liability with 21,559 shares, increasing direct ownership by 39% to 130,738 units (SEC Form 4)
- Chief Executive Officer Gudonis Paul R was granted 146,909 shares, increasing direct ownership by 11% to 1,434,679 units (SEC Form 4)
- Chief Financial Officer Henry David A was granted 68,644 shares and covered exercise/tax liability with 25,310 shares, increasing direct ownership by 10% to 470,163 units (SEC Form 4)
- SEC Form S-8 filed by Myomo Inc.
- SEC Form 10-Q filed by Myomo Inc.
- Myomo Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Myomo Reports Second Quarter 2026 Financial and Operating Results